About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT03884426

Genetic and Phenotypic Characteristics of Mitral Valve Prolapse

Phenotypic characterisation of MVP by echocardiography in families. Identification of genes involved in MVP.

Lead sponsor: Nantes University Hospital•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Thierry Le Tourneau, PU-PH

CONTACT

0617908670 thletourneau@yahoo.fr

Sponsors

Lead Sponsor

Nantes University Hospital

Collaborators

University Hospital, Brest
Rennes University Hospital

After clinical identification of patients with MVP, doctors organize 1st degree relative familial screening. A comprehensive echocardiography was carried out along with clinical examination. All echo data were stored for off-line analysis by a sonographer in our Core-lab. Blood was sample at the time of echocardiography in adult patients for DNA analyses. Follow-up for mitral valve changes will be performed after 5 years.

Age

All ages

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Patients of any age
•with typical mitral valve prolapse
•relatives examined during familial screening

Exclusion Criteria

•Refusal of the patient

Related studies

RECRUITINGPhase 3

A Phase 3 Study of NTLA-2001 in ATTRv-PN

NCT06672237 · Neuromuscular Disease, Neuromuscular Diseases (NMD), and more

Natural History of Type 1 Interferonopathies: Insights From a European Cohort

NCT07040774 · Genetic Disease, Immune Dysfunction, and more

AI-Based Shape and Function Analysis of Mitral Valve Prolapse Using 3D Ultrasound

NCT07384871 · Mitral Valve Prolapse, Myxomatous Mitral Valve Degeneration

Genotype-phenotype Characterization Study on Genetic Diseases With Immune and Neurological Dysfunctions

NCT06235580 · Genetic Diseases, Immune Dysfunction, and more

Arrhythmic Mitral Valve Prolapse Detection Using Long-term Ambulatory Rhythm Monitoring

NCT06378996 · Mitral Valve Prolapse, Ventricular Arrythmia

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 30, 2021Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment1,000

Start dateDec 2010

Last updatedAug 30, 2021

Condition

Mitral Valve Prolapse Genetic Disease

Locations shown

Brest University Hospital

Brest

Nantes University Hospital

Nantes

Rennes University Hospital

Rennes

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 30, 2021Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions